PA
ABBV icon

Prossimo Advisors’s AbbVie ABBV Stock Holding History

Prossimo Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,792
Closed -$333K – 32
2025
Q2 		$333K Sell
1,792
-74
-4% -$13.8K 0.27% 94
2025
Q1 		$391K Buy
1,866
+26
+1% +$5.05K 0.29% 99
2024
Q4 		$327K Buy
1,840
+17
+0.9% +$3.13K 0.24% 108
2024
Q3 		$360K Buy
1,823
+22
+1% +$4.11K 0.26% 107
2024
Q2 		$309K Buy
1,801
+205
+13% +$34K 0.28% 105
2024
Q1 		$291K Sell
1,596
-55
-3% -$9.48K 0.56% 49
2023
Q4 		$256K Buy
1,651
+40
+2% +$5.83K 0.54% 52
2023
Q3 		$240K Sell
1,611
-53
-3% -$7.78K 0.57% 50
2023
Q2 		$224K Buy
+1,664
New +$244K 0.22% 114

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prossimo Advisors's ABBV Position: Q3 2025 in Review

Prossimo Advisors sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 1,792 shares — an estimated $333K sold.

Prossimo Advisors first reported a position in ABBV in Q2 2023 and held it in 9 quarters. The position peaked at $391K in Q1 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Prossimo Advisors reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Prossimo Advisors sold 1,792 AbbVie shares in Q3 2025, an estimated $333K.
  • Prossimo Advisors first reported a position in AbbVie in Q2 2023 and held it in 9 quarters.
  • Prossimo Advisors's AbbVie position peaked at $391K in Q1 2025.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Prossimo Advisors's 13F filing for Q3 2025, filed 28 Oct 2025.